Host Media Contact News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Host media contact. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Host Media Contact Today - Breaking & Trending Today

OncoHost Secures $8 Million Series B Funding Round to Advance its AI-Powered Precision Oncology Platform


Share this article
Share this article
BINYAMINA, Israel, Jan. 19, 2021 /PRNewswire/  OncoHost, global leader in host response profiling for improved personalized cancer therapy, today announced the completion of a $8 million Series B funding round. The funding will help finance OncoHost s ongoing clinical trials, open a US-based affiliate and prepare for the upcoming launch of PROphet
®, the company s machine learning-based Host Response Profiling platform that combines proteomic analysis with AI to predict patient response to immunotherapy, providing clinicians with potential combination strategies to overcome treatment resistance.
The funding round was led by OurCrowd, an investment platform built for accredited investors and institutions to invest in start-ups, early-stage companies and venture funds. They were joined by a group of family offices and private investors. ....

H Efa , Marc Andreesen , Ofer Sharon , Kellie Hanson , Jon Medved , Host Response Profiling , Host Media Contact , ஏச் எபா , மார்க் அன்றீஸ்ன் , ஓபெர் ஷரோன் , ஜான் மெட்‌வெட் , தொகுப்பாளர் பதில் ப்ரோஃபைலிஂக் , தொகுப்பாளர் மீடியா தொடர்பு ,

OncoHost Welcomes Nobel Prize Winner to Scientific Advisory Board


OncoHost Welcomes Nobel Prize Winner to Scientific Advisory Board
USA - English
News provided by
Share this article
Share this article
BINYAMINA, Israel, Jan. 11, 2021 /PRNewswire/ OncoHost, global leader in host response profiling for improved personalized cancer therapy, announced today that renowned biologist and winner of The Nobel Prize in Chemistry, Professor Aaron Ciechanover, has joined the company s scientific advisory board.
We are delighted to have Professor Ciechanover, an eminent researcher and physician, join our team. His profound scientific knowledge in protein biology and fundamental discoveries in protein turnover that awarded him the 2004 Nobel Prize in Chemistry will be an invaluable contribution to our research efforts in identifying effective personalized cancer treatments, said Dr. Ofer Sharon, CEO of OncoHost. OncoHost s unique approach to host response analysis and our methods to overcome therapy resistance will be further impr ....

United States , H Efa , Aaaron Ciechanover , Ofer Sharon , Kellie Hanson , Prnewswire Oncohost , European Molecular Biology Organization , Albert Lasker Prize For Basic Medical Research , Chinese Academy Of Sciences , Israel Prize For Biological Research , Rappaport Technion Integrated Cancer Center , Israeli National Academy Of Sciences , National Academies Of Sciences , Israel Institute Of Technology , Nobel Prize , Professor Aaron Ciechanover , Professor Ciechanover , Lasker Prize , Basic Medical Research , Biological Research , Israeli National Academy , National Academies , Foreign Associate , Chinese Academy , Foreign Member , Rappaport Faculty ,